Kontour Medical Technology Stock Operating Margin
| 688314 Stock | 29.50 0.44 1.51% |
Kontour Medical Technology fundamentals help investors to digest information that contributes to Kontour Medical's financial success or failures. It also enables traders to predict the movement of Kontour Stock. The fundamental analysis module provides a way to measure Kontour Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kontour Medical stock.
Kontour | Operating Margin |
Kontour Medical Technology Company Operating Margin Analysis
Kontour Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Kontour Medical Technology has an Operating Margin of 0.0%. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The operating margin for all China stocks is 100.0% lower than that of the firm.
Kontour Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kontour Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kontour Medical could also be used in its relative valuation, which is a method of valuing Kontour Medical by comparing valuation metrics of similar companies.Kontour Medical is currently under evaluation in operating margin category among its peers.
Kontour Fundamentals
| Current Valuation | 2.06 B | ||||
| Price To Book | 3.75 X | ||||
| Price To Sales | 7.77 X | ||||
| Revenue | 275.03 M | ||||
| EBITDA | 106.76 M | ||||
| Net Income | 75.51 M | ||||
| Total Debt | 37.97 M | ||||
| Cash Flow From Operations | 85.22 M | ||||
| Total Asset | 675.79 M | ||||
| Retained Earnings | 164.9 M | ||||
| Working Capital | 346.95 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 675.79 M |
About Kontour Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kontour Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kontour Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kontour Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Kontour Stock
Kontour Medical financial ratios help investors to determine whether Kontour Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kontour with respect to the benefits of owning Kontour Medical security.